Medical Oncologist
CION Cancer Clinics
Surveillance for RUNX1 carriers: what is checked and when | CION Cancer Clinics
Surveillance for a RUNX1 carrier means regular blood counts, a baseline bone marrow test and a clear plan for bleeding. Your haematologist sets the schedule, and it changes if your counts do. The aim is to notice marrow changes early, before a leukaemia is advanced. This page explains which tests are used, what a typical plan looks like, and which symptoms should not wait. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does surveillance for a RUNX1 carrier involve?
- Which tests are used to watch a RUNX1 carrier?
- What does a typical surveillance plan look like?
- The words you will see, in plain language
- Four things carriers tell us, and what is actually true
- What this page cannot tell you
- Common questions about RUNX1 surveillance
The short answer
What does surveillance for a RUNX1 carrier involve?
It means regular blood counts, one baseline bone marrow test, a plan for safe bleeding control, and a named haematologist who knows your history. The aim is to spot changes in the marrow early, before a leukaemia is advanced, and to keep everyday bleeding safe.
The aim is early warning
No test can stop a RUNX1 fault from acting. What surveillance can do is notice when the marrow starts to change. A slow fall in the platelet count, new changes in the red or white cells, or a new gene fault in a group of blood cells can all be picked up before symptoms appear.
How often you will be seen
Your haematologist sets the schedule. A full blood count is commonly checked once or twice a year for a well adult carrier, and more often if the count is drifting. Children are usually followed by a paediatric haematologist on a similar plan.
Why there is no single fixed timetable
RUNX1 familial platelet disorder is rare. Current recommendations come from expert groups rather than large trials, and centres differ in the detail. Studies so far are small, so expect your plan to be adjusted as your own results build up.
The most useful record you can keep is every blood count report, in date order, in one folder.The tests
Which tests are used to watch a RUNX1 carrier?
Four kinds of check make up most plans. Not every carrier needs all four at every visit.
Full blood count and film
The core test. It counts platelets, red cells and white cells, and a doctor looks at the cells under a microscope. Your own baseline matters more than the laboratory's normal range.
A baseline bone marrow test
A sample is taken from the back of the hip bone under local anaesthetic. It shows how the marrow looks at the start, so later changes can be compared against it.
Repeated when
- The blood count changes from your usual
- New abnormal cells appear on the film
- Your haematologist suspects early marrow change
A sensitive gene panel
Some centres test blood or marrow for new faults building up in a group of cells. How to act on small changes is still being worked out, so ask what your result would change.
A bleeding assessment
Questions about bruising, nosebleeds, periods and past surgery, and sometimes a platelet function test. This decides what cover you need before dental work or an operation.
Not sure whether this applies to you?
Ask an oncologistOver time
What does a typical surveillance plan look like?
-
When the fault is first found
A full blood count, a blood film, a bleeding history and usually a baseline marrow test. You are given a named haematologist and a written plan.
-
At each routine visit
A blood count, questions about bruising, tiredness and infections, and a comparison with your earlier results. Most visits are short and uneventful.
-
When something changes
A falling count or new abnormal cells leads to a repeat marrow test. This is the moment surveillance exists for, and acting early widens the choices.
-
Before any procedure
Dental extractions, surgery and childbirth are planned ahead. The team may give a medicine to help clotting or a platelet transfusion.
-
Thinking ahead about transplant
Some teams do tissue typing early and discuss donor options while you are well. Related donors must be tested for the family fault first.
!
One thing that cannot wait
If a cut or nosebleed will not stop despite firm pressure, if you vomit blood or pass black stools, or if a carrier has a bad headache after a knock to the head, go to the nearest emergency department the same day. Tell them about the platelet disorder straight away. Do not take aspirin or ibuprofen for the pain, because both make platelets work less well.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your reports
The words you will see, in plain language
- Full blood count
- A routine blood test that counts each type of blood cell. It is the backbone of surveillance.
- Blood film
- A drop of blood looked at under a microscope, to check the shape and maturity of the cells.
- Bone marrow biopsy
- A small sample of marrow and bone taken with a needle from the hip, to see how blood is being made.
- Platelet function test
- A test of how well platelets stick together, rather than how many there are.
- Clonal change
- A group of blood cells sharing a new fault and growing faster than the rest. It is a warning sign, not leukaemia.
- Tissue typing
- A blood test of immune markers, called HLA, used to find a matching stem cell donor.
Commonly believed
Four things carriers tell us, and what is actually true
"My count has always been low, so a low result means nothing."
Your usual low is your baseline. What matters is a change from it. That is why every report should be compared with the last few.
"I feel fine, so I can skip this year's test."
Early marrow change usually causes no symptoms at all. The blood test is the only way to see it.
"A bone marrow test every year is the safest plan."
Most plans repeat the marrow test when the blood count changes rather than on a fixed date. Your haematologist will explain which approach suits you.
"A painkiller from the chemist is harmless."
Aspirin and ibuprofen-type painkillers weaken platelets further. Paracetamol is usually the safer choice, but check with your doctor.
Being straight with you
What this page cannot tell you
It cannot set your personal schedule. How often you are seen depends on your age, your counts, your family history and the variant you carry. Only your haematologist can decide that, and it may change over the years.
It cannot interpret a result for you
A dip in a count can be an infection, a medicine or early marrow change. What your specific variant means is a question for the counsellor who ordered the test. What a change in your blood count means is a question for your haematologist.
Who this does not apply to
This plan is for people with a confirmed inherited RUNX1 fault. It does not apply to someone whose RUNX1 fault was found only inside leukaemia cells, or to a relative who has tested negative for the family variant. Most people with a low platelet count do not need this kind of follow-up.
If you live in a district, ask whether routine blood counts can be done locally and sent to your haematologist, so only key visits need travel.Questions we are asked
Common questions about RUNX1 surveillance
At what age should surveillance start?
Usually from the time the fault is found, including in children. Leukaemia linked to RUNX1 can appear in childhood, and bleeding matters at any age. A paediatric haematologist will set a plan for a child that fits school and family life.
Is a bone marrow test painful?
The area is numbed first. Most people feel pressure and a brief sharp pull when the sample is drawn, then soreness for a few days. Children are often given sedation. It is not repeated routinely unless something changes.
Which symptoms should make me call early?
New or worse bruising, bleeding gums, tiny red spots on the skin, unusual tiredness, breathlessness, fevers or repeated infections, and bone pain. None of these means leukaemia on its own, but each is a reason to get a blood count sooner.
Can surveillance prevent leukaemia?
No. It aims to find marrow changes early, when there are more treatment choices, including a planned stem cell transplant. Whether early action improves long-term results is still being studied.
What should I tell my dentist?
That you have an inherited platelet disorder and bleed more than expected. Ask them to speak with your haematologist before any extraction. Carry a card or a note on your phone that states the condition and your haematologist's name.
What about heavy periods or pregnancy?
Heavy periods are common in carriers and can be treated. Tell your gynaecologist about the disorder. In pregnancy, the obstetric and haematology teams plan the delivery together, including how any bleeding will be handled.
Can blood tests be done closer to home?
Often, yes. A routine count from a reliable local laboratory can be sent to your haematologist. Keep the originals, and try to use the same laboratory each time so results are easier to compare.
Does surveillance cost a lot?
Routine blood counts are inexpensive. The marrow test and gene panels cost more and are needed less often. Ask the team for estimates, and whether Aarogyasri or Ayushman Bharat covers any part in your situation.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Hematologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. One helpline books a consultation at any of these centres, and your team will tell you where counselling and testing take place.
Warangal
Vizag
Sources
- GeneReviews (NCBI) — RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies
- National Cancer Institute (PDQ) — RUNX1-Familial Platelet Disorder (PDQ)
- Cancer Research UK — Acute myeloid leukaemia (AML)
- MedlinePlus Genetics — RUNX1 gene
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
RUNX1 positive: what happens nextThe first steps after a positive resultRUNX1 mutation: which cancers and what riskWhat surveillance is watching for, and whyFamilial platelet disorder with leukaemia riskThe bleeding side of the condition in more detailWhy a RUNX1 result changes who can be a stem cell donorWhy donor planning starts early for carriers
Talk to us
Need a surveillance plan after a RUNX1 result?
Share your result and any blood count reports you have. We will arrange a haematologist to set a plan that fits your age, your counts and where you live. One helpline serves every CION centre.